Report Detail

Global Sarcopenia Treatment Market Size study, by Type (Presarcopenia, Sarcopenia, Severe Sarcopenia), Application (Hospitals, Clinics, Ambulatory Surgical Centers) and Regional Forecasts 2018-2025

TABLE OF CONTENTS

    Chapter 1. Executive Summary

    • 1.1. Market Snapshot
    • 1.2. Key Trends
    • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
      • 1.3.1. Sarcopenia Treatment Market, by Type, 2015-2025 (USD Billion)
      • 1.3.2. Sarcopenia Treatment Market, by Application, 2015-2025 (USD Billion)
      • 1.3.3. Sarcopenia Treatment Market, by Region, 2015-2025 (USD Billion)
    • 1.4. Estimation Methodology
    • 1.5. Research Assumption

    Chapter 2. Global Sarcopenia Treatment Market Definition and Scope

    • 2.1. Objective of the Study
    • 2.2. Market Definition & Scope
      • 2.2.1. Industry Evolution
      • 2.2.2. Scope of the Study
    • 2.3. Years Considered for the Study
    • 2.4. Currency Conversion Rates

    Chapter 3. Global Sarcopenia Treatment Market Dynamics

    • 3.1. See Saw Analysis
      • 3.1.1. Market Drivers
      • 3.1.2. Market Challenges
      • 3.1.3. Market Opportunities

    Chapter 4. Global Sarcopenia Treatment Market Industry Analysis

    • 4.1. Porter’s 5 Force Model
      • 4.1.1. Bargaining Power of Buyers
      • 4.1.2. Bargaining Power of Suppliers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
      • 4.1.6. Futuristic Approach to Porter’s 5 Force Model
    • 4.2. PEST Analysis
      • 4.2.1. Political Scenario
      • 4.2.2. Economic Scenario
      • 4.2.3. Social Scenario
      • 4.2.4. Technological Scenario
    • 4.3. Key Buying Criteria
    • 4.4. Regulatory Framework
    • 4.5. Investment Vs Adoption Scenario
    • 4.6. Analyst Recommendation & Conclusion

    Chapter 5. Global Sarcopenia Treatment Market, by Type

    • 5.1. Market Snapshot
    • 5.2. Market Performance - Potential Model
    • 5.3. Sarcopenia Treatment Market, Sub Segment Analysis
      • 5.3.1. Presarcopenia
        • 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.2. Sarcopenia
        • 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 5.3.3. Severe Sarcopenia
        • 5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

      Chapter 6. Global Sarcopenia Treatment Market, by Application

      • 6.1. Market Snapshot
      • 6.2. Market Performance - Potential Model
      • 6.3. Sarcopenia Treatment Market, Sub Segment Analysis
        • 6.3.1. Hospitals
          • 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 6.3.2. Clinics
          • 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 6.3.3. Ambulatory Surgical Centers
          • 6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

        Chapter 7. Global Sarcopenia Treatment Market, by Regional Analysis

        • 7.1. Sarcopenia Treatment Market, Regional Market Snapshot (2015-2025)
        • 7.2. North America Sarcopenia Treatment Market Snapshot
          • 7.2.1. U.S.
            • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.2.2. Canada
            • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion
        • 7.3. Europe Sarcopenia Treatment Market Snapshot
          • 7.3.1. U.K.
            • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.3.2. Germany
            • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.3.3. Rest of Europe
            • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.4. Asia Sarcopenia Treatment Market Snapshot
          • 7.4.1. China
            • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.4.2. India
            • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.4.3. Japan
            • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.4.4. Rest of Asia Pacific
            • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.5. Latin America Sarcopenia Treatment Market Snapshot
          • 7.5.1. Brazil
            • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.5.2. Mexico
            • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.6. Rest of The World
          • 7.6.1. South America
            • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.6.2. Middle East and Africa
            • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

          Chapter 8. Competitive Intelligence

          • 8.1. Company Market Share (Subject to Data Availability)
          • 8.2. Top Market Strategies
          • 8.3. Company Profiles
            • 8.3.1. Radius Health
              • 8.3.1.1. Overview
              • 8.3.1.2. Financial (Subject to Data Availability)
              • 8.3.1.3. Product Summary
              • 8.3.1.4. Recent Developments
            • 8.3.2. GTX
            • 8.3.3. Five Prime Therapeutics
            • 8.3.4. EZ Facility
            • 8.3.5. Club Manager
            • 8.3.6. Sports Engine
            • 8.3.7. Team Sideline
            • 8.3.8. Team Tracky

          Chapter 9. Research Process

          • 9.1. Research Process
            • 9.1.1. Data Mining
            • 9.1.2. Analysis
            • 9.1.3. Market Estimation
            • 9.1.4. Validation
            • 9.1.5. Publishing

    Global sarcopenia treatment market is valued approximately USD 2208.4 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period 2018-2025. Reduction of muscle mass considering Sarcopenia leads to loss in muscle function aligned with high changes of functional impairment, mortality and disability in the adult population. Furthermore, malnutrition is one of the emerging causes for early age sarcopenia specially in developing regions. Also changing lifestyle and physical inactivity has led to early age sarcopenia. Increasing prevalence and lack of permanent cure has led to several research and development across the disease. Further changing lifestyles has increased the impact of the disease among the adults in their early 30s. Several initiatives have been taken against the diseases. One such initiative is Canada Sarcopenia Foundation, which is dedicated to preventing and reverse the course of metabolic disease and sarcopenia.

    Increasing prevalence of sarcopenia across the adults at early age and the rising awareness levels of the consumers is anticipated to drive the growth in pre-sarcopenia market over the forecast period. On the basis of type the Global Sarcopenia market is segmented into Pre-Sarcopenia, Sarcopenia, Severe Sarcopenia. Currently, the market is dominated by sarcopenia market with a majority revenue share of 43.55% in 2017. Sarcopenia is getting very prevalent across the age group of 50-80 years. Severe sarcopenia is more prevalent across people of age group above 80 years. Severe sarcopenia affects both physical performance and strength which includes loss of muscle mass.

    Knowledge about sarcopenia has increased during the past decade. Various epidemiological and pathophysiological aspects are better understood today than few years ago. Researchers have found that muscle pathology can cause adverse health effect and it is evident with various studies that this adverse consequence are treatable, and the effects can be delayed through certain treatment strategies. The advancement of sarcopenia treatment such as Ursolic acid is a pentaciclyc triterpenoid found in apples. This acid has the potential to reduce muscle weakness and atrophy associated aging. Ursolic acid stimulate an increase in muscle by repressing atrophy-associated skeletal muscle gene expression. These is the major factor that spur the growth of investment for drug and supplement development in Sarcopenia treatment market. The rapid increasing investment for drug and supplement development changes the nature of pricing and competition in the market are also become a reason to enhance the market growth over the coming years.

    The regional analysis of global sarcopenia treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to surging prevalence of cancer and chronic diseases. Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2018-2025 due to escalating prevalence of geriatric population and surging incidences of diabetes.

    Market player included in this report are:
    Abbott Laboratories
    Pfizer Inc
    Novartis AG
    Glaxosmithkline Plc
    Nestle SA
    Bayer AG
    Sanofi SA
    Amway

    The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

    By Type:
    Presarcopenia
    Sarcopenia
    Severe Sarcopenia

    By Application:
    Hospitals
    Clinics
    Ambulatory Surgical Centers


    By Regions:
    North America
    U.S.
    Canada
    Europe
    UK
    Germany
    Asia Pacific
    China
    India
    Japan
    Latin America
    Brazil
    Mexico
    Rest of the World

    Furthermore, years considered for the study are as follows:

    Historical year – 2015, 2016
    Base year – 2017
    Forecast period – 2018 to 2025

    Target Audience of the Global Sarcopenia Treatment Market in Market Study:

    Key Consulting Companies & Advisors
    Large, medium-sized, and small enterprises
    Venture capitalists
    Value-Added Resellers (VARs)
    Third-party knowledge providers
    Investment bankers


    Summary:
    Get latest Market Research Reports on Sarcopenia Treatment . Industry analysis & Market Report on Sarcopenia Treatment is a syndicated market report, published as Global Sarcopenia Treatment Market Size study, by Type (Presarcopenia, Sarcopenia, Severe Sarcopenia), Application (Hospitals, Clinics, Ambulatory Surgical Centers) and Regional Forecasts 2018-2025. It is complete Research Study and Industry Analysis of Sarcopenia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,950.00
    $5,550.00
    3,113.13
    4,374.15
    3,537.22
    4,970.01
    435,989.15
    612,592.35
    275,293.28
    386,804.48
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report